A mild phenoxysilyl linker for self-immolative release of antibody-drug conjugates

被引:4
|
作者
Wei, Ding [1 ,2 ,3 ]
Mao, Yurong [2 ,3 ]
Wang, Huihui [2 ,3 ]
Qu, Siqi [2 ,3 ]
Chen, Jiakang [2 ]
Li, Jiusheng [1 ]
Jiang, Biao [2 ]
Chen, Hongli [2 ]
机构
[1] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai 201210, Peoples R China
[2] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
关键词
Antibody-drug conjugates; Self-immolative release; Phenoxysilyl linker; Combretastatin A4 (CA4); DELIVERY; ACTIVATION; PAYLOADS; DESIGN;
D O I
10.1016/j.cclet.2022.108091
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Self-immolative linkers have been widely used to construct prodrugs to improve their efficacy and safety. In this study, we report the use of phenoxysilyl linker as a self-immolative unit to prepare antibody-drug conjugates (ADCs). Phenoxysily based ADC Ate-PPS-CA4 was prepared and its release was systematically investigated by mass spectrometry. Biological evaluation showed that Ate-PPS-CA4 displayed the ability to target delivery and self-immolative release the active payload CA4 on PD-L1 positive cells MDA-MB-231. As the same with its payload CA4, it could arrest the cell cycle to the G2/M phase and induced changes in cell morphology at the dose of its IC50. The development of this linker with novel drug release mechanisms will expand the methodology to construct ADCs, especially for non-internalizing ADCs by extracellular cleavage.(c) 2023 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] A dual-enzyme cleavable linker for antibody-drug conjugates
    Bargh, Jonathan D.
    Walsh, Stephen J.
    Ashman, Nicola
    Isidro-Llobet, Albert
    Carroll, Jason S.
    Spring, David R.
    CHEMICAL COMMUNICATIONS, 2021, 57 (28) : 3457 - 3460
  • [22] Antibody-drug conjugates: recent advances in conjugation and linker chemistries
    Kyoji Tsuchikama
    Zhiqiang An
    Protein & Cell, 2018, 9 (01) : 33 - 46
  • [23] A versatile acid-labile linker for antibody-drug conjugates
    Finniss, Mathew C.
    Chu, Kevin S.
    Bowerman, Charles J.
    Luft, J. Christopher
    Haroon, Zishan A.
    DeSimone, Joseph M.
    MEDCHEMCOMM, 2014, 5 (09) : 1355 - 1358
  • [24] Hybrid Polyester Self-Immolative Polymer Nanoparticles for Controlled Drug Release
    Gambles, Michael T.
    Fan, Bo
    Borecki, Aneta
    Gillies, Elizabeth R.
    ACS OMEGA, 2018, 3 (05): : 5002 - 5011
  • [25] Elucidating the role of drug-linker hydrophobicity in the disposition of antibody-drug conjugates
    Doronina, Svetlana O.
    Setter, Jocelyn R.
    Bovee, Tim D.
    Anderson, Martha E.
    Jonas, Mechtild
    Daniho, Steven
    Kostner, Heather
    Senter, Peter D.
    Lyon, Robert P.
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Antibody-Drug Conjugates
    Kumar, Amit
    White, Jason
    Christie, R. James
    Dimasi, Nazzareno
    Gao, Changshou
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 50: PLATFORM TECHNOLOGIES IN DRUG DISCOVERY AND VALIDATION, 2017, 50 : 441 - 480
  • [27] Antibody-Drug Conjugates
    Ashutosh A. Kulkarni
    Hovhannes J. Gukasyan
    Pharmaceutical Research, 2015, 32 : 3451 - 3452
  • [28] Antibody-Drug Conjugates
    Cao Gang
    Huang Zuogang
    Cheng Jiefei
    Jiang Biao
    PROGRESS IN CHEMISTRY, 2014, 26 (2-3) : 467 - 477
  • [29] Antibody-Drug Conjugates
    Peng, Li
    Chen, Xiaoyuan
    BIOCONJUGATE CHEMISTRY, 2015, 26 (11) : 2169 - 2169
  • [30] Antibody-drug conjugates
    Zolot, Rachel S.
    Basu, Satarupa
    Million, Ryan P.
    NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (04) : 259 - 260